Booz & Co.’s 2012 China Innovation Survey consisted of more than 100 executives at Chinese firms and multinational companies (MNCs) in the industry, automotive, health/life sciences, consumer goods, and chemical and energy sectors. Of surveyed MNCs, 45% “perceive Chinese competitors as equally or more innovative than themselves.” The two areas in which MNCs rated Chinese […]
Largely due to the lower cost of renewable power equipment, global renewable energy investments grew 16.8% in 2011 to reach a high of $257 billion, according to the Renewable Energy Policy Network for the 21st Century (REN21). Venture capital spending grew 5% to $2.5 billion. Government R&D investment, corporate R&D investment, private-equity funding and funding […]
Conducted in February, KPMG’s Global Manufacturing Outlook survey questioned 241 executives from the aerospace and defense, metals, engineering and industrial products sectors, conglomerates. All questions concerned the time period of the next one to two years. Seventy-five percent of respondents have a positive outlook. When asked what factors would be most vital to profits, 65% […]
In 2011, sales of new drugs introduced 2007–2011 were $40 billion, or 7% of global sales not including generics and over-the-counter drugs. Small molecule drugs represented 56% of sales, and oncology products and immunomodulators constituted 15%. In 2016, sales of new drugs launched 2011–2016 are expected to reach $58 billion, or 9% of global sales. […]
Reinach, Switzerland 6/26/12—Measurement instrumentation firm Endress+Hauser has acquired SpectraSensors for an undisclosed amount. SpectraSensors develops, manufactures and distributes laser-based gas analytical instruments utilizing tunable diode lasers. Based in Texas, the company has annual sales of $30 million and employs 90 people. “With SpectraSensors we are expanding our range in the field of analytics to include […]
Washington, DC 6/28/12—In a filing with the SEC, Thermo Fisher Scientific disclosed that it is seeking to sell its laboratory workstations business, which is part of its Laboratory Products and Services segment, in order to exit noncore businesses. The workstations business had 2011 sales of $180 million and an operating loss of $6 million, which […]
Santa Clara, CA 6/25/12—Microarray firm Affymetrix has completed its $315 million purchase of eBioscience, a provider of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics (see IBO 5/15/12). “Through the acquisition of eBio we now have a blue-chip portfolio of cell-based assays that diversify our business and open up important new […]
Hilden, Germany and Germantown, MD 6/25/12—QIAGEN has announced the acquisition of next-generation sequencer (NGS) developer Intelligent Biosystems for an undisclosed amount. Further details of the acquisition were unavailable. QIAGEN disclosed the acquisition as part of a broader announcement of its entry into the NGS market. The company plans to launch a complete workflow for NGS, […]
LIMS (laboratory information management systems) lie at the heart of many laboratories’ informatics systems. Strategic Directions International’s (SDi’s) April report entitled “2012 Lab Informatics Survey of End-Users” is based on a survey of LIMS end-users and provides insight into important topics for LIMS vendors, including the use of LIMS with other software systems, how and […]
Slowly but surely, the cosmetics industry is moving toward in vitro toxicity testing and away from traditional in vivo tests. The shift is due to regulation as well as a desire to more accurately predict human response and significantly reduce the number of animals required for toxicity testing. The €67 billion ($93 billion = €0.72 […]
Pay Invoice
Latest Blogs
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
